MyAverix Finance
F · Healthcare
HYLORIS PHARMA. S.A. (52U)
Biotechnology
HYLORIS PHARMA. S.A. (52U) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 52U
HYLORIS PHARMA. S.A. (52U) — FAQ
What is 52U's P/E ratio?
The price-to-earnings (P/E) ratio for HYLORIS PHARMA. S.A. (52U) is 25.00 (data as of 2026-05-23).
Does HYLORIS PHARMA. S.A. pay a dividend?
Dividend yield is not available in the current snapshot for HYLORIS PHARMA. S.A. (52U). Check the MyAverix Finance app for the latest dividend data.
What sector is HYLORIS PHARMA. S.A. in?
HYLORIS PHARMA. S.A. (52U) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 52U listed on?
52U is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.